Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15(th)–16(th) February 2019, Doha, Qatar

The progress in the isolation and characterization of tumor antigen (TA)-specific T lymphocytes and in the genetic modification of immune cells allowed the clinical development of adoptive cell therapy (ACT). Several clinical studies highlighted the striking clinical activity of T cells engineered t...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrouahen, Bella, Elnaggar, Muhammad, Al-Mohannadi, Anjud, Kizhakayil, Dhanya, Bonini, Chiara, Benjamin, Reuben, Brentjens, Renier, Buchholz, Christian J., Casorati, Giulia, Ferrone, Soldano, Locke, Frederick L., Martin, Francisco, Schambach, Axel, Turtle, Cameron, Veys, Paul, van der Vliet, Hans J., Maccalli, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874217/
https://www.ncbi.nlm.nih.gov/pubmed/33584653
http://dx.doi.org/10.3389/fimmu.2020.589381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874217/
https://www.ncbi.nlm.nih.gov/pubmed/33584653
http://dx.doi.org/10.3389/fimmu.2020.589381

Ejemplares similares